INTENSIVE CARE FOR COMPLICATIONS FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE AGRANULOCYTOSIS PERIOD IN PATIENTS WITH AUTOIMMUNE DISEASES. ijms 2026, 6 (4), 764-769. https://doi.org/10.55640/.